Indian Economy - FY22 GDP Growth Forecast Revised To 9.0%, Led By Vaccine Ramp Up, Government Spending: ICRA
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICRA Research Report
We have revised FY22 real gross domestic product forecast to 9.0% from 8.5%, citing the brightening prospects for H2 FY22, benefitting from the rapid ramp-up in Covid-19 vaccine administration, healthy advance estimates of kharif output and withdrawal of expenditure management measures related to the Government of India’s spending.
The widening coverage of Covid-19 vaccines is likely to boost confidence, which will in turn re-energise demand for contact-intensive services, helping to revive the portions of the economy affected most by the pandemic.
Moreover, the robust kharif harvest is likely to sustain the consumption demand from the farm sector.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.